Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:STGW
NasdaqGS:STGWMedia

A Look At Stagwell (STGW) Valuation As HarrisQuest Expansion And AI Push Gain Traction

Why Stagwell’s HarrisQuest Expansion Matters for Investors Stagwell (STGW) recently expanded The Harris Poll’s HarrisQuest platform across Europe, giving regional brands access to always on, data driven brand and reputation tracking that global companies already use for key marketing decisions. See our latest analysis for Stagwell. Stagwell’s recent HarrisQuest expansion and focus on artificial intelligence backed services comes as the shares trade at US$6.08, with a 30 day share price return...
ENXTPA:KER
ENXTPA:KERLuxury

Kering Jewelry Push And New Leaders Put Focus On Valuation And Risks

Kering has created a new entity, Kering Jewelry, to group its jewelry brands and industrial operations into a single platform. Jean-Marc Duplaix has been appointed CEO of Kering Jewelry while continuing as Group COO. Pierre Houlès has joined as Chief Digital, AI, and IT Officer to lead the Group’s digital and AI agenda. For investors tracking ENXTPA:KER, these changes arrive after a mixed share price pattern. The stock trades at about €248.3, with a 6.0% gain over the past week and a 27.9%...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller Secures Supply And Raises Prices While Refocusing On Balance Sheet

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Should Biogen’s ALT-B4 Alzheimer’s Delivery Deal Reshape How BIIB Investors View Its Risk Profile?

In March 2026, Alteogen announced an exclusive license deal giving Biogen rights to develop subcutaneous formulations for two biologic products using ALT-B4 Hybrozyme technology, while new data from Eisai and Biogen showed strong long-term real-world treatment persistence for intravenous lecanemab in Alzheimer’s patients. Together, these developments highlight Biogen’s push to expand patient-friendly biologic delivery and deepen its presence in Alzheimer’s care through therapies patients are...
NYSE:RNG
NYSE:RNGSoftware

Why RingCentral (RNG) Is Down 6.0% After Soft Billings And Inefficient Customer Acquisition Spend - And What's Next

Recently, RingCentral reported solid quarterly results, but weaker billings and softer demand indicators have raised fresh questions about the strength of its underlying growth engine. An unusual red flag is the negative customer acquisition cost payback period, suggesting current sales and marketing spending may not be efficiently converting into profitable, long-term customers. Next, we'll explore how concerns over weak billings and soft demand could reshape RingCentral's existing...
NYSE:HLF
NYSE:HLFPersonal Products

Herbalife (HLF) Valuation Check After Recent Share Price Volatility

Herbalife (HLF) is back on investors' radar after recent share price pressure, with the stock showing a 25.2% decline over the past month following an earlier 8.1% gain in the past 3 months. See our latest analysis for Herbalife. At a share price of $14.41, Herbalife’s recent 1 month share price return of a 25.2% decline contrasts with a 12.4% year to date share price gain and a 68.14% 1 year total shareholder return. This suggests that momentum has recently faded after a stronger run. If...
NYSE:DHR
NYSE:DHRLife Sciences

A Look At Danaher (DHR) Valuation After Recent Share Price Weakness

Why Danaher (DHR) Is Drawing Attention Now Danaher (DHR) is back on many watchlists after a period of weaker share performance, including a 13% decline over the past month and a 21% decline over the past 3 months. See our latest analysis for Danaher. At a share price of $181.52, Danaher’s recent 13% 1 month share price decline and 21% 3 month share price decline extend a tougher run, while the 1 year total shareholder return of 11% and 5 year total shareholder return of 7% indicate pressure...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity Vote On Special Meetings And Stock Retention Meets Valuation Gap

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...
NYSE:RL
NYSE:RLLuxury

Assessing Ralph Lauren (RL) Valuation After Recent Share Price Weakness And Cooling Momentum

Recent share price weakness in Ralph Lauren (RL), including a month return of about 13% and roughly 8% over the past 3 months, has drawn fresh attention to how investors are weighing its current valuation and fundamentals. See our latest analysis for Ralph Lauren. At a share price of $327.82, Ralph Lauren’s recent 1 month share price return of about 13% and 3 month share price return of roughly 8% sit against a 1 year total shareholder return of 53.8%. This suggests momentum has cooled...
HLSE:SANOMA
HLSE:SANOMAMedia

Assessing Sanoma Oyj (HLSE:SANOMA) Valuation As Shares Show Mixed Recent Returns

Sanoma Oyj share performance snapshot Sanoma Oyj (HLSE:SANOMA) has drawn fresh attention after recent trading left the share price at €8.88, with the stock showing a 2.4% decline over the past day and a 2.3% decline over the past week. Over the past month, Sanoma’s return stands at a 1.4% decline, and over the past 3 months the stock has logged a 3.6% decline, while the one year total return is 5.3% and the 3 year total return is 26.4%. See our latest analysis for Sanoma Oyj. Recent trading...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Assessing Whether Costco Wholesale (COST) Is Overvalued After Recent Steady Share Price Momentum

Event context and recent stock performance Costco Wholesale (COST) has drawn fresh attention after recent trading left the shares with a small one-day gain and a modest rise over the past week, while the month shows a slight negative return. See our latest analysis for Costco Wholesale. Set against a 12.65% 90 day share price return and a 15.14% year to date share price return, Costco Wholesale’s recent moves suggest momentum has been building. The 3 year total shareholder return of 106.23%...
NYSE:FAF
NYSE:FAFInsurance

How Investors Are Reacting To First American Financial (FAF) Surging Past Revenue Expectations

In its most recent quarter, First American Financial posted an exceptional performance with revenue rising 21.6% year on year, beating analyst forecasts by 15.2% and signaling strong recent business momentum. This combination of solid top-line growth and outperformance versus expectations highlights how the company’s operations have recently been executing ahead of what the market had modeled. We’ll now examine how this stronger-than-expected quarterly revenue performance might influence...
TSX:BDT
TSX:BDTConstruction

Bird Construction’s (TSX:BDT) Margin Beat Is In But What Does It Reveal About Its Backlog Quality?

In the most recent quarter, Bird Construction reported better-than-anticipated profit margins despite sector-wide challenges facing engineering, construction, and heavy-equipment companies, while peers generally expressed optimism about future demand drivers such as defense, power, nuclear, and infrastructure spending. This margin outperformance suggests Bird’s existing backlog and project mix may be converting into earnings more efficiently than many had expected, potentially reinforcing...
NYSE:DHT
NYSE:DHTOil and Gas

A Look At DHT Holdings (DHT) Valuation After Its New Shelf Registration Filing

Why DHT Holdings Filed a New Shelf Registration DHT Holdings (DHT) has filed an omnibus shelf registration covering common stock, preferred stock, warrants, and rights. This filing gives the tanker owner flexibility to raise capital or pursue corporate actions when market conditions appear suitable. See our latest analysis for DHT Holdings. The shelf registration comes after a strong run, with DHT’s 90-day share price return of 48.12% and year-to-date gain of 54.17%, while the 1-year total...
NYSE:ICE
NYSE:ICECapital Markets

ICE’s Polymarket Bet and Derivatives Surge Might Change The Case For Investing In Intercontinental Exchange (ICE)

In recent days, Intercontinental Exchange, Inc. completed a new US$600 million cash investment in prediction market platform Polymarket and reported record trading activity across its global derivatives and NYSE equities markets following geopolitical tensions in the Middle East. Together, these moves underscore how ICE is pairing high-intensity usage of its existing trading infrastructure with experimental exposure to emerging prediction markets. We’ll now examine how ICE’s expanded...
SEHK:1788
SEHK:1788Capital Markets

Guotai Junan International Holdings (SEHK:1788) Valuation After Strong 2025 Earnings And Higher Dividend Payout

Guotai Junan International Holdings (SEHK:1788) has drawn fresh attention after reporting sharply higher full year 2025 revenue, net income, and earnings per share, along with a larger dividend recommendation for shareholders. See our latest analysis for Guotai Junan International Holdings. The full year 2025 earnings and higher dividend have arrived after a mixed share price stretch. Guotai Junan International Holdings is now trading at HK$2.38, with a 30 day share price return of 17.07%...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

Is It Time To Reassess eToro Group (ETOR) After This Year’s Share Price Slide?

If you are wondering whether eToro Group at around US$29.05 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The share price closed at US$29.05, with a 1.3% decline over the past week, a 10.5% decline over the past month, and an 18.6% decline year to date, which may signal shifting views on both risk and potential. Recent coverage has focused on eToro Group as a publicly listed trading platform provider that gives investors access to a wide...
NasdaqGS:VRNS
NasdaqGS:VRNSSoftware

Varonis Systems (VRNS) Is Down 10.6% After Exiting On-Premise Business To Focus On AI SaaS

Earlier this month, Varonis Systems unexpectedly announced it will discontinue its on-premises solution, which contributed about 15% of revenue, after missing quarterly projections and shifting its focus more fully to its SaaS platform. At the same time, the company launched its new Varonis Atlas AI security platform and prepared high-profile presentations at RSA Conference 2026, underscoring a quicker pivot toward AI-driven, cloud-based data security. We’ll now examine how the accelerated...
TSE:9602
TSE:9602Entertainment

How Toho’s Leadership Shakeup Across Film, Theater, and Real Estate Will Impact Toho (TSE:9602) Investors

On March 18, 2026, Toho Co., Ltd.’s board approved sweeping leadership changes, including Representative Director Yoshishige Shimatani stepping down to become Corporate Adviser and the planned retirement of several senior Executive Officers across its real estate, theatrical, and cinema businesses. These shifts reshuffle decision‑making power across Toho’s core operating groups, potentially signaling an internal rethink of how its film, theater, and property operations are led. With these...
ENXTBR:SYENS
ENXTBR:SYENSChemicals

Syensqo Bond Redemption Reshapes Debt Profile And Undervalued Share Story

Syensqo has redeemed €500 million of senior bonds that were originally due in 2027. This move completes a wider debt refinancing step following the company’s recent spin off. The early redemption changes the company’s debt profile and may influence future interest costs. The bond redemption comes at a time when Syensqo (ENXTBR:SYENS) shares trade around €49.0. The stock has seen a 12.6% gain over the past week, while returns over the past month, year to date, and past year show declines of...
NYSE:CBT
NYSE:CBTChemicals

Is Cabot (CBT) Pricing Look Attractive After Mixed Recent Share Performance?

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program

Novo Nordisk (NYSE:NVO) has received an FDA National Priority Voucher tied to a higher dose of its obesity drug Wegovy. This is the fourth such voucher granted for the higher dose version, marking another key regulatory step for the product. The decision comes as the FDA prepares a June public meeting to review and discuss the controversial priority voucher program. Lawmakers have called for more transparency around how these vouchers are awarded and used, which could influence future...
ENXTPA:URW
ENXTPA:URWRetail REITs

A Look At Unibail-Rodamco-Westfield (ENXTPA:URW) Valuation After Recent Share Price Weakness

Unibail-Rodamco-Westfield (ENXTPA:URW) is drawing investor attention after recent share price moves, with the stock declining 1.6% over the past day and 11.3% over the past month. See our latest analysis for Unibail-Rodamco-Westfield. That recent 11.3% 30 day share price decline sits against a flat year to date share price return and a much stronger 1 year total shareholder return of 23.9%, suggesting some of the earlier momentum is cooling as investors reassess risk and future prospects. If...
TASE:IDIN
TASE:IDINInsurance

IDI Insurance Q3 Net Margin Improvement Tests Cautious Dividend Narratives

Fresh off its FY 2025 update, I.D.I. Insurance (TASE:IDIN) reported Q3 revenue of ₪1.0b and basic EPS of ₪5.6, set against trailing twelve month revenue of ₪3.7b and EPS of ₪21.21 that reflect 23.6% earnings growth over the past year. Over recent periods, the company has seen revenue move from ₪3.2b to ₪3.7b on a trailing basis, with EPS stepping up from ₪14.70 to ₪21.21, while net profit margin shifted from 7.2% to 8.4%. For investors, that combination of higher earnings and firmer margins...